loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 70134 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ABRAXIS PHARM (1)

filter

01 INJECTABLE;INJECTION (1)

filter

01 DISCN (1)

filter

01 BRETYLIUM TOSYLATE (1)

filter

01 No (1)

Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
INJECTABLE; INJECT...
50MG/ML
1986-04-29
70134
BRETYLIUM TOSYLATE
DISCN
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 70134

Looking for FDA Orange Book APPLICATION 70134 1

19

ABRAXIS PHARM, based in U.S.A, is a pharmaceutical company.

One of their notable products is BRETYLIUM TOSYLATE, with a corresponding application number 70134.

Regulatory Information DISCN

With a dosage strength 50MG/ML

Dosage Form Route INJECTABLE; INJECTION

Reference Listed Drug No

Approved since 1986-04-29

Post Enquiry
POST ENQUIRY